HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timothy W Morris Selected Research

Dysgeusia (Parageusia)

12/2013The safety of besifloxacin ophthalmic suspension 0.6 % used three times daily for 7 days in the treatment of bacterial conjunctivitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Timothy W Morris Research Topics

Disease

13Bacterial Conjunctivitis
05/2015 - 05/2009
4Eye Infections
01/2016 - 08/2009
4Infections
05/2012 - 07/2008
3Bacterial Infections (Bacterial Infection)
01/2016 - 07/2008
1Cataract (Cataracts)
01/2015
1Conjunctivitis
11/2014
1Dysgeusia (Parageusia)
12/2013
1Pseudomonas Infections
01/2012

Drug/Important Bio-Agent (IBA)

14besifloxacinFDA Link
05/2015 - 05/2009
10SuspensionsIBA
05/2015 - 05/2009
5FluoroquinolonesIBA
05/2012 - 08/2009
4Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 07/2008
4Moxifloxacin (Avelox)FDA Link
05/2015 - 09/2009
4Ophthalmic Solutions (Eye Drops)IBA
05/2015 - 09/2009
2Capsules (Microcapsules)IBA
11/2014 - 12/2011
2Virulence Factors (Pathogenicity Factors)IBA
11/2014 - 12/2011
2RifamycinsIBA
07/2008 - 07/2008
1VaccinesIBA
11/2014
1Tetracycline (Achromycin)FDA LinkGeneric
12/2011
1Erythromycin (Erycette)FDA LinkGeneric
12/2011
1Trimethoprim (Proloprim)FDA LinkGeneric
12/2011
1Azithromycin (Zithromax)FDA LinkGeneric
12/2011
1MacrolidesIBA
10/2011
1LactamsIBA
10/2011
1Chloramphenicol (Chloromycetin)FDA Link
10/2011
1Cephalosporins (Cephalosporin Antibiotics)IBA
10/2011
1AminoglycosidesIBA
10/2011
1GlycopeptidesIBA
10/2011
1QuinolonesIBA
07/2008
1CBR 2092IBA
07/2008